Farjah Algahtani: Joining the Global Conversation at ISTH 2026
Farjah Algahtani, Director of Epidemiology and Public Health Research at King Saud University, Professor Of Hematology, shared a post on LinkedIn:
“Excited to be at ISTH 2026 in Paris!
Honored to join colleagues, researchers, and healthcare professionals from around the world at the 34th Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Paris.
The congress brings together more than 6,000 experts to share the latest advances in thrombosis, hemostasis, vascular biology, and patient care.
As someone passionate about clinical research and public health, I look forward to engaging in discussions that bridge scientific innovation with real-world practice.
From emerging therapies and evidence-based medicine to global collaboration, meetings like ISTH remind us that advancing patient outcomes requires not only groundbreaking science but also strong partnerships across disciplines and countries.
These conversations have the power to shape future research, improve healthcare delivery, and ultimately enhance the lives of patients affected by thrombotic and bleeding disorders.
Looking forward to connecting with colleagues, exchanging ideas, and contributing to meaningful collaborations throughout the congress.”

Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH